Vertex Pharmaceuticals Incorporated (ETR:VX1)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	89,947	89,031	90,236	63,873	48,093	52,861
Market Cap Growth	-15.79%	-1.33%	41.27%	32.81%	-9.02%	8.32%
Enterprise Value	80,913	85,097	81,207	55,296	42,380	47,896
PE Ratio	29.04	-193.61	29.29	22.53	24.37	22.97
Forward PE	20.94	22.66	24.44	18.83	16.42	21.78
PEG Ratio	-	1.21	1.92	0.58	1.62	1.06
PS Ratio	9.25	9.39	10.62	8.31	7.38	9.90
PB Ratio	6.15	6.30	5.96	5.33	5.53	7.07
P/TBV Ratio	5.32	6.33	6.03	5.38	5.65	7.17
P/FCF Ratio	-	-130.90	31.42	18.91	23.20	20.52
P/OCF Ratio	-	-210.02	29.64	17.97	21.14	18.88
EV/Sales Ratio	8.24	8.97	9.56	7.19	6.50	8.97
EV/EBITDA Ratio	19.69	-3847.55	23.51	14.42	16.94	18.77
EV/EBIT Ratio	21.23	-424.57	24.62	14.92	17.70	19.49
EV/FCF Ratio	27.15	-125.12	28.28	16.37	20.45	18.59
Debt / Equity Ratio	0.09	0.09	0.04	0.06	0.09	0.10
Debt / EBITDA Ratio	0.37	-60.09	0.18	0.18	0.31	0.30
Debt / FCF Ratio	0.44	-1.95	0.22	0.21	0.37	0.30
Asset Turnover	0.49	0.49	0.48	0.57	0.60	0.62
Inventory Turnover	1.17	1.57	2.10	2.66	2.85	3.28
Quick Ratio	2.00	2.17	3.60	4.46	4.04	4.02
Current Ratio	2.52	2.69	3.99	4.83	4.46	4.33
Return on Equity (ROE)	21.66%	-3.15%	22.99%	27.67%	24.93%	36.71%
Return on Assets (ROA)	14.01%	2.22%	15.49%	21.41%	18.95%	24.76%
Return on Capital (ROIC)	23.87%	4.48%	44.17%	72.18%	59.10%	65.73%
Return on Capital Employed (ROCE)	20.19%	-1.22%	22.16%	32.27%	26.29%	33.89%
Earnings Yield	3.44%	-0.52%	3.41%	4.44%	4.10%	4.35%
FCF Yield	3.31%	-0.76%	3.18%	5.29%	4.31%	4.87%
Buyback Yield / Dilution	1.58%	1.42%	0.50%	-0.02%	2.61%	0.77%
Total Shareholder Return	-	1.42%	0.50%	-0.02%	2.61%	0.77%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.